$AAGH
America Great Health Stock $aagh

$aagh Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-K Financial Statement

#000118518522001238 Filed on October 31, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022
Revenue	$51.94K	$104.7K	$104.6K
YoY Change			-46.52%
Cost Of Revenue	$27.50K	$1.588M	$1.588M
YoY Change		588214.81%	1000.65%
Gross Profit	$24.44K	-$1.484M	-$1.484M
YoY Change		549455.56%	-2989.59%
Gross Profit Margin	47.05%	-1417.87%	-1417.9%
Selling, General & Admin	$152.7K	$3.250M	$3.250M
YoY Change	-48.78%	1926.24%	1002.13%
% of Gross Profit	624.68%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.476K	$5.910K	$5.905K
YoY Change
% of Gross Profit	6.04%
Operating Expenses	$152.7K	$3.250M	$3.250M
YoY Change	-48.78%	1926.25%	1002.13%
Operating Profit	-$128.2K	-$4.734M	-$4.734M
YoY Change	-56.98%	2846.29%	1843.71%
Interest Expense	$64.54K	-$190.9K	$190.9K
YoY Change	-294.16%	844.16%	-848.98%
% of Operating Profit
Other Income/Expense, Net	-$64.53K	$70.00	-$190.8K
YoY Change	-161432.5%		648.56%
Pretax Income	-$192.8K	-$4.925M	-$4.925M
YoY Change	-41.81%	2622.47%	1730.49%
Income Tax	$0.00
% Of Pretax Income
Net Earnings	-$192.8K	-$4.866M	-$4.925M
YoY Change	-41.81%	2589.97%	1730.49%
Net Earnings / Revenue	-371.12%	-4649.93%	-4706.19%
Basic Earnings Per Share
Diluted Earnings Per Share	$0.00	-$230.70	-$230.70
COMMON SHARES
Basic Shares Outstanding	21.09B shares
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q3	2022 Q2	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$74.57K	$62.64K	$62.64K
YoY Change	-51.05%	-84.19%	-84.19%
Cash & Equivalents	$74.57K	$62.64K
Short-Term Investments
Other Short-Term Assets	$16.97K	$16.96K	$16.96K
YoY Change	-85.66%	-7.32%	-7.32%
Inventory	$121.5K	$116.1K	$116.1K
Prepaid Expenses
Receivables	$645.00	$918.00	$920.00
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$213.7K	$196.6K	$196.6K
YoY Change	-39.16%	-59.33%	-59.33%
LONG-TERM ASSETS
Property, Plant & Equipment	$22.14K	$23.62K	$117.5K
YoY Change	-84.18%	-83.08%	-15.83%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$34.05K	$13.84K	$13.84K
YoY Change		1876.57%	1877.14%
Total Long-Term Assets	$140.5K	$139.6K	$139.6K
YoY Change	0.38%	-0.03%	-0.04%
TOTAL ASSETS
Total Short-Term Assets	$213.7K	$196.6K	$196.6K
Total Long-Term Assets	$140.5K	$139.6K	$139.6K
Total Assets	$354.2K	$336.1K	$336.1K
YoY Change	-27.89%	-46.05%	-46.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.434M	$1.438M	$1.438M
YoY Change	3586.04%	2412.71%	2412.71%
Accrued Expenses	$66.84K	$70.90K	$70.90K
YoY Change	30.27%	39.93%	39.93%
Deferred Revenue
YoY Change
Short-Term Debt	$153.3K	$183.9K	$183.9K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.781M	$2.757M	$2.757M
YoY Change	544.31%	537.66%	537.66%
LONG-TERM LIABILITIES
Long-Term Debt	$1.132M	$1.032M	$1.032M
YoY Change	42.84%	77.29%	77.29%
Other Long-Term Liabilities	$473.4K	$407.1K	$407.1K
YoY Change	649.15%	433.78%	433.78%
Total Long-Term Liabilities	$1.132M	$1.439M	$1.439M
YoY Change	32.29%	118.58%	118.58%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.781M	$2.757M	$2.757M
Total Long-Term Liabilities	$1.132M	$1.439M	$1.439M
Total Liabilities	$4.387M	$4.197M	$4.138M
YoY Change	240.74%	284.71%	279.32%
SHAREHOLDERS EQUITY
Retained Earnings	-$8.604M	-$8.422M
YoY Change		136.86%
Common Stock	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$3.964M	-$3.802M	-$3.802M
YoY Change
Total Liabilities & Shareholders Equity	$354.2K	$336.1K	$336.1K
YoY Change	-27.89%	-46.05%	-46.05%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022
OPERATING ACTIVITIES
Net Income	-$192.8K	-$4.866M	-$4.925M
YoY Change	-41.81%	2589.97%	1730.49%
Depreciation, Depletion And Amortization	$1.476K	$5.910K	$5.905K
YoY Change
Cash From Operating Activities	-$143.2K	-$160.9K	-$1.480M
YoY Change	-68.8%	-30.7%	349.48%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	$16.85K
YoY Change	-100.0%	-100.0%	-233.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	$0.00	-$16.85K
YoY Change	-100.0%	-100.0%	33.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$97.50K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$155.1K	117.1K	$1.163M
YoY Change	-32.02%	-80.98%	57.62%
NET CHANGE
Cash From Operating Activities	-$143.2K	-160.9K	-$1.480M
Cash From Investing Activities	$0.00	0.000	-$16.85K
Cash From Financing Activities	$155.1K	117.1K	$1.163M
Net Change In Cash	$11.93K	-43.82K	-$333.7K
YoY Change	-104.89%	-111.81%	-184.26%
FREE CASH FLOW
Cash From Operating Activities	-$143.2K	-$160.9K	-$1.480M
Capital Expenditures	$0.00	$0.00	$16.85K
Free Cash Flow	-$143.2K	-$160.9K	-$1.497M
YoY Change	-67.91%	-26.7%	372.79%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-27873
CY2022	dei	Entity Registrant Name EntityRegistrantName	America Great Health
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	WY
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0178621
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	1609 W Valley Blvd Unit 338A
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Alhambra
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	91803
CY2022	dei	City Area Code CityAreaCode	(888)
CY2022	dei	Local Phone Number LocalPhoneNumber	988-1333
CY2022	dei	Security12b Title Security12bTitle	None
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	No
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	21090218148	shares
CY2022	dei	Auditor Name AuditorName	WWC, P.C.
CY2022	dei	Auditor Location AuditorLocation	San Mateo, CA
CY2022	dei	Auditor Firm AuditorFirmId	1171
CY2022Q2	us-gaap	Cash Cash	62643	usd
CY2021Q2	us-gaap	Cash Cash	396136	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	918	usd
CY2021Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	0	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	116060	usd
CY2021Q2	us-gaap	Inventory Net InventoryNet	7848	usd
CY2022Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	0	usd
CY2021Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	61136	usd
CY2022Q2	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	16964	usd
CY2021Q2	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	17600	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	196585	usd
CY2021Q2	us-gaap	Assets Current AssetsCurrent	482720	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	93886	usd
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	126927	usd
CY2022Q2	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	8218	usd
CY2021Q2	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	0	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	13836	usd
CY2021Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	700	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	23618	usd
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12671	usd
CY2022Q2	us-gaap	Assets Assets	336143	usd
CY2021Q2	us-gaap	Assets Assets	623018	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1437522	usd
CY2021Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	57209	usd
CY2022Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	102	usd
CY2021Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	0	usd
CY2022Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	183932	usd
CY2021Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	0	usd
CY2022Q2	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	334112	usd
CY2021Q2	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	800	usd
CY2022Q2	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	573859	usd
CY2021Q2	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	323750	usd
CY2022Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	157000	usd
CY2021Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	0	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	70895	usd
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	50672	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2757422	usd
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	432431	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	22991	usd
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	76255	usd
CY2022Q2	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	384073	usd
CY2021Q2	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	0	usd
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1032138	usd
CY2021Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	582159	usd
CY2022Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1439202	usd
CY2021Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	658414	usd
CY2022Q2	us-gaap	Liabilities Liabilities	4196624	usd
CY2021Q2	us-gaap	Liabilities Liabilities	1090845	usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2021Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21090218148	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21090218148	shares
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21070866399	shares
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21070866399	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4619991	usd
CY2021Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3087869	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	160	usd
CY2021Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-8421849	usd
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3555696	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-3801698	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-467827	usd
CY2022Q2	us-gaap	Minority Interest MinorityInterest	-58783	usd
CY2021Q2	us-gaap	Minority Interest MinorityInterest	0	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3860481	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-467827	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	336143	usd
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	623018	usd
CY2022	us-gaap	Revenues Revenues	104648	usd
CY2021	us-gaap	Revenues Revenues	195671	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1588453	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	144318	usd
CY2022	us-gaap	Gross Profit GrossProfit	-1483805	usd
CY2021	us-gaap	Gross Profit GrossProfit	51353	usd
CY2022	us-gaap	Selling Expense SellingExpense	86316	usd
CY2021	us-gaap	Selling Expense SellingExpense	0	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3163977	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	294913	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3250293	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	294913	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-4734098	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-243560	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	5	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	0	usd
CY2022	us-gaap	Interest Expense InterestExpense	190916	usd
CY2021	us-gaap	Interest Expense InterestExpense	20044	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-5450	usd
CY2022	us-gaap	Other Income OtherIncome	73	usd
CY2021	us-gaap	Other Income OtherIncome	0	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-190838	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-25494	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4924936	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-269054	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-4924936	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-269054	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-58783	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4866153	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-269054	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-160	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	0	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4866313	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-269054	usd
CY2022	aagh	Earnings Per Share Basic And Diluted1 EarningsPerShareBasicAndDiluted1	0
CY2021	aagh	Earnings Per Share Basic And Diluted1 EarningsPerShareBasicAndDiluted1	0
CY2022	aagh	Weighted Average Number Of Share Outstanding Basic And Diluted1 WeightedAverageNumberOfShareOutstandingBasicAndDiluted1	21090049276	shares
CY2021	aagh	Weighted Average Number Of Share Outstanding Basic And Diluted1 WeightedAverageNumberOfShareOutstandingBasicAndDiluted1	20438554050	shares
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-215007	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2064	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	135	usd
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	700	usd
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	5450	usd
CY2021	aagh	Imputed Interest ImputedInterest	7885	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-269054	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-467827	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-467827	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	97500	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1361133	usd
CY2022	aagh	Imputed Interest ImputedInterest	11893	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	160	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	61596	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-4924936	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3860481	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-4924936	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-269054	usd
CY2022	us-gaap	Depreciation Depreciation	5905	usd
CY2021	us-gaap	Depreciation Depreciation	0	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	61596	usd
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1361133	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	2064	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	135	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-5450	usd
CY2022	aagh	Imputed Interest ImputedInterest	11893	usd
CY2021	aagh	Imputed Interest ImputedInterest	7885	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	918	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	0	usd
CY2022	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-61771	usd
CY2021	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	58549	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	13138	usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	0	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	0	usd
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	17600	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	108211	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6708	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1380314	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	7936	usd
CY2022	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	157000	usd
CY2021	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	0	usd
CY2022	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	194318	usd
CY2021	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	0	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	333415	usd
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-800	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-1479858	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-329241	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1479858	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-329241	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16851	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	12671	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16851	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-12671	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	97500	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2022	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	183932	usd
CY2021	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	639734	usd
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	582159	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	250109	usd
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	235331	usd
CY2022	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-8219	usd
CY2021	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-79608	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1163056	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	737882	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-333653	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	395970	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	396136	usd
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	166	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	160	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	62643	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	396136	usd
CY2022	us-gaap	Interest Paid InterestPaid	0	usd
CY2021	us-gaap	Interest Paid InterestPaid	0	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	800	usd
CY2022	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	0	usd
CY2021	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	5450	usd
CY2017Q1	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	16155746000	shares
CY2017Q1	us-gaap	Proceeds From Sales Of Business Affiliate And Productive Assets ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets	100	usd
CY2020Q2	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	510000000	shares
CY2021Q3	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	50000	usd
CY2021Q3	us-gaap	Number Of Units In Real Estate Property NumberOfUnitsInRealEstateProperty	53	pure
CY2021Q3	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	19	pure
CY2021Q3	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	7626286.37	usd
CY2021Q3	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	7000000	usd
CY2021Q3	aagh	Real Estate Description Of Terms RealEstateDescriptionOfTerms	The purchase price shall be paid as follows: (i) $1,000,000 on execution of the Agreement, (ii) $2,000,000 within 60 days thereof and (iii) the remainder by April 10, 2022. The Agreement is subject to customary closing conditions, including, satisfactory due diligence.
CY2021Q4	aagh	Class Of Warrant Or Rights Granted ClassOfWarrantOrRightsGranted	500000	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.01
CY2021Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P24M
CY2022Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	500000	shares
CY2021Q4	us-gaap	Investment Owned Balance Shares InvestmentOwnedBalanceShares	20000000	shares
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-4924936	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1479858	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3860481	usd
CY2022Q2	us-gaap	Cash Cash	62643	usd
CY2022Q2	us-gaap	Prepaid Rent PrepaidRent	13836	usd
CY2021Q2	us-gaap	Prepaid Rent PrepaidRent	11136	usd
CY2022Q2	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	0	usd
CY2021Q2	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	50000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Estimates</b></p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The preparation of the financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Significant estimates include accounting for potential liabilities and the assumptions made in valuing stock instruments issued for services, debt and equity investment. Actual results could differ from those estimates.</p><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2022Q2	us-gaap	Foreign Currency Exchange Rate Translation1 ForeignCurrencyExchangeRateTranslation1	1	pure
CY2022Q2	us-gaap	Foreign Currency Exchange Rate Translation1 ForeignCurrencyExchangeRateTranslation1	1	pure
CY2022Q2	us-gaap	Cash Uninsured Amount CashUninsuredAmount	3194	usd
CY2021Q2	us-gaap	Cash Uninsured Amount CashUninsuredAmount	127672	usd
CY2022Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	7956	usd
CY2022Q2	us-gaap	Other Receivables OtherReceivables	13836	usd
CY2021Q2	us-gaap	Other Receivables OtherReceivables	61136	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	482	usd
CY2021Q1	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	79362534	shares
CY2022Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	183932	usd
CY2022Q2	us-gaap	Other Receivables OtherReceivables	13836	usd
CY2021Q2	us-gaap	Other Receivables OtherReceivables	61136	usd
CY2022Q2	us-gaap	Due To Other Related Parties Current And Noncurrent DueToOtherRelatedPartiesCurrentAndNoncurrent	35190	usd
CY2022Q1	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	400000	shares
CY2022Q2	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	240000	shares
CY2022Q2	us-gaap	Long Term Debt LongTermDebt	1221892	usd
CY2021Q2	us-gaap	Long Term Debt LongTermDebt	582159	usd
CY2022Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.20	pure
CY2022Q2	us-gaap	Long Term Debt Term LongTermDebtTerm	P5Y
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	189754	usd
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	12159	usd
CY2022	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	1032138	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	189754	usd
CY2022Q2	us-gaap	Long Term Debt LongTermDebt	1221892	usd
CY2022Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	50000	usd
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21090218148	shares
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21070866399	shares
CY2022Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	1300000	shares
CY2022Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.075
CY2021Q1	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	48220124	shares
CY2021Q1	aagh	Number Of Shareholders NumberOfShareholders	28	pure
CY2021Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.00001
CY2021Q1	aagh	Number Of Unrelated Parties NumberOfUnrelatedParties	54	pure
CY2021Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.00001
CY2021Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	794	usd
CY2021Q2	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	50000000	shares
CY2021Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.00001
CY2021Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	500	usd
CY2021Q2	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	6621905	shares
CY2021Q2	aagh	Number Of Unrelated Parties NumberOfUnrelatedParties	12	pure
CY2021Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.00001
CY2021Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	66	usd
CY2021Q2	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	1300000	shares
CY2021Q2	aagh	Number Of Unrelated Parties NumberOfUnrelatedParties	6	pure
CY2021Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.00001
CY2021Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	13	usd
CY2021Q2	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	7140000	shares
CY2021Q2	aagh	Number Of Unrelated Parties NumberOfUnrelatedParties	5	pure
CY2021Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.00001
CY2021Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	71	usd
CY2021Q2	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	450000	shares
CY2021Q2	aagh	Number Of Unrelated Parties NumberOfUnrelatedParties	3	pure
CY2021Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.00001
CY2021Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	5	usd
CY2021Q2	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	11300000	shares
CY2021Q2	aagh	Number Of Unrelated Parties NumberOfUnrelatedParties	22	pure
CY2021Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.00001
CY2021Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	113	usd
CY2022Q1	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	10967465	shares
CY2022Q1	aagh	Number Of Unrelated Parties NumberOfUnrelatedParties	28	pure
CY2022Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.1195
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1310612	usd
CY2022Q2	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	75523	shares
CY2022Q2	aagh	Number Of Unrelated Parties NumberOfUnrelatedParties	1	pure
CY2022Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.0685
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	5173	usd
CY2022Q2	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	240000	shares
CY2022Q2	aagh	Number Of Unrelated Parties NumberOfUnrelatedParties	2	pure
CY2022Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.06495
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	15588	usd
CY2022Q2	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	500000	shares
CY2022Q2	aagh	Number Of Unrelated Parties NumberOfUnrelatedParties	1	pure
CY2022Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.0595
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	29750	usd
CY2022Q2	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	46921	shares
CY2022Q2	aagh	Number Of Unrelated Parties NumberOfUnrelatedParties	1	pure
CY2022Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.0002
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	9	usd
CY2022Q1	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	400000	shares
CY2022Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	100000	usd
CY2022Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.075
CY2022Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	30000	usd
CY2021Q2	us-gaap	Long Term Debt Maturities Repayment Terms LongTermDebtMaturitiesRepaymentTerms	During the investment period, if the stock can be normally traded in the stock market, and the market value of this part of AAGH stock exceeds the principal and interest of loan for 30 consecutive trading days. The remaining principal and interest of loan will be forgiven.
CY2021Q2	us-gaap	Long Term Debt Maturities Repayment Terms LongTermDebtMaturitiesRepaymentTerms	During the investment period, if the stock can be normally traded in the stock market, and the market value of this part of AAGH stock exceeds the principal and interest of loan for 30 consecutive trading days. The remaining principal and interest of loan will be forgiven.
CY2021Q2	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	20000	usd
CY2021Q2	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	30000	usd
CY2021Q2	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	200000	shares
CY2021Q4	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	240000	shares
CY2021Q4	aagh	Stock Shares Not Yet Issued StockSharesNotYetIssued	60000	shares
CY2021Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	100000	usd
CY2021Q2	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	1000000	shares
CY2021Q4	us-gaap	Long Term Debt Maturities Repayment Terms LongTermDebtMaturitiesRepaymentTerms	During the investment period, if the stock can be normally traded in the stock market, and the market value of this part of AAGH stock exceeds the principal and interest of loan for 30 consecutive trading days. The remaining principal and interest of loan will be forgiven.
CY2021Q4	us-gaap	Long Term Debt Maturities Repayment Terms LongTermDebtMaturitiesRepaymentTerms	During the investment period, if the stock can be normally traded in the stock market, and the market value of this part of AAGH stock exceeds the principal and interest of loan for 30 consecutive trading days. The remaining principal and interest of loan will be forgiven.
CY2021Q4	us-gaap	Long Term Debt Maturities Repayment Terms LongTermDebtMaturitiesRepaymentTerms	During the investment period, if the stock can be normally traded in the stock market, and the market value of this part of AAGH stock exceeds the principal and interest of loan for 30 consecutive trading days. The remaining principal and interest of loan will be forgiven.
CY2022Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	295000	usd
CY2022Q1	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	15000000	shares
CY2022	aagh	Unified Corporate Income Tax Rate UnifiedCorporateIncomeTaxRate	0.25	pure
CY2022	aagh	Corporate Income Tax Rate For Qualified High Technology And Science Enterprises CorporateIncomeTaxRateForQualifiedHighTechnologyAndScienceEnterprises	0.15	pure
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	73941	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	23278	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	0	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	0	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	97219	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	3333	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.07	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.07	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5920531	usd
CY2021Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	995595	usd
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5920531	usd
CY2021Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	995595	usd
CY2022Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2021Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	33041	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	74975	usd
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y9M
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.05	pure
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	97219	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	93886	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	70895	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	22991	usd
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001098009
CY2021Q4	dei	Entity Public Float EntityPublicFloat	0	usd
CY2022	dei	No Trading Symbol Flag NoTradingSymbolFlag	true

Files In Submission

Name	View Source	Status
aagh-20220630_cal.xml	Edgar Link	unprocessable
0001185185-22-001238-index-headers.html	Edgar Link	pending
0001185185-22-001238-index.html	Edgar Link	pending
0001185185-22-001238.txt	Edgar Link	pending
0001185185-22-001238-xbrl.zip	Edgar Link	pending
aagh-20220630.xsd	Edgar Link	pending
amgreat20220630_10k.htm	Edgar Link	pending
exb_1img1.jpg	Edgar Link	pending
ex_430986.htm	Edgar Link	pending
ex_430987.htm	Edgar Link	pending
ex_431337.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
amgreat20220630_10k_htm.xml	Edgar Link	completed
aagh-20220630_pre.xml	Edgar Link	unprocessable
aagh-20220630_def.xml	Edgar Link	unprocessable
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
wwc_logo1.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
aagh-20220630_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AAGH
America Great Health Stock $aagh

2022 Q3 Form 10-K Financial Statement

#000118518522001238 Filed on October 31, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AAGH America Great Health Stock $aagh

2022 Q3 Form 10-K Financial Statement

#000118518522001238 Filed on October 31, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AAGH
America Great Health Stock $aagh